Am. J. Respir. Crit. Care Med., Vol 151, No. 6, 06 1995, 2109-2115.
Review of fungus-induced asthmatic reactions
HF Kauffman, JF Tomee, TS van der Werf, JG de Monchy and GK Koeter
Department of Allergology, University Hospital, Groningen, The Netherlands.
Fungus-induced obstructive airway disease in atopic individuals can be
differentiated into two categories: first, uncomplicated asthmatic
reactions due to high but transient exposure to fungal spores (fungal
asthma), resulting in a TH2-type response with immunoglobulin E- mediated
reactions and eosinophilic inflammation; and second, a more complex
asthmatic reaction due to colonization of the mucus-epithelial surface by
virulent protease-producing fungi. The latter condition stimulates as
exaggerated immunological response including all subclasses of antibodies
directed against the microorganism and an intense eosinophilic infiltrate
of the airways. The authors propose that the exaggerated inflammatory
response in allergic bronchopulmonary fungosis damages epithelial cells and
underlying tissue cells, resulting in inefficient elimination of the
microorganisms and damage to matrix proteins of the lung tissue by
proteases released by both the fungi and degranulating eosinophils. The
positive effects of corticosteroids in the treatment of allergic
bronchopulmonary aspergillosis probably results from the dampening of the
inflammatory response and an increase of the efficiency of killing the
fungi. Sensitization to fungi is high in childhood and declines rapidly
with age, suggesting that younger children may be less proficient in
clearing fungi from the airways. We propose that insufficient treatment of
fungal asthma may result in damage to the bronchial mucosa and formation of
bronchiectasis.
This article has been cited by other articles:

|
 |

|
 |
 
S. J. Park, M. T. Wiekowski, S. A. Lira, and B. Mehrad
Neutrophils Regulate Airway Responses in a Model of Fungal Allergic Airways Disease
J. Immunol.,
February 15, 2006;
176(4):
2538 - 2545.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Inoue, Y. Matsuwaki, S.-H. Shin, J. U. Ponikau, and H. Kita
Nonpathogenic, Environmental Fungi Induce Activation and Degranulation of Human Eosinophils
J. Immunol.,
October 15, 2005;
175(8):
5439 - 5447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Schuh, K. Blease, S. L. Kunkel, and C. M. Hogaboam
Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus
Am J Physiol Lung Cell Mol Physiol,
July 1, 2002;
283(1):
L198 - L204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J D Leuppi, S H Downs, S R Downie, G B Marks, and C M Salome
Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms
Thorax,
June 1, 2002;
57(6):
518 - 523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Barker
Bronchiectasis
N. Engl. J. Med.,
May 2, 2002;
346(18):
1383 - 1393.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Maiz, M. Cuevas, S. Quirce, J. F. Canon, A. Pacheco, A. Sousa, and H. Escobar
Serologic IgE Immune Responses Against Aspergillus fumigatus and Candida albicans in Patients With Cystic Fibrosis
Chest,
March 1, 2002;
121(3):
782 - 788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Noverr, G. B. Toews, and G. B. Huffnagle
Production of Prostaglandins and Leukotrienes by Pathogenic Fungi
Infect. Immun.,
January 1, 2002;
70(1):
400 - 402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Blease, C. Jakubzick, J. M. Schuh, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
IL-13 Fusion Cytotoxin Ameliorates Chronic Fungal-Induced Allergic Airway Disease in Mice
J. Immunol.,
December 1, 2001;
167(11):
6583 - 6592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. DOWNS, T. Z. MITAKAKIS, G. B. MARKS, N. G. CAR, E. G. BELOUSOVA, J. D. LEUPPI, W. XUAN, S. R. DOWNIE, A. TOBIAS, and J. K. PEAT
Clinical Importance of Alternaria Exposure in Children
Am. J. Respir. Crit. Care Med.,
August 1, 2001;
164(3):
455 - 459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi and T. F. Murphy
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review
Clin. Microbiol. Rev.,
April 1, 2001;
14(2):
336 - 363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Chest,
March 1, 2001;
119(3):
762 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. E. Alexis, J. Soukup, S. Nierkens, and S. Becker
Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma
Am J Physiol Lung Cell Mol Physiol,
February 1, 2001;
280(2):
L369 - L375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Blease, B. Mehrad, N. W. Lukacs, S. L. Kunkel, T. J. Standiford, and C. M. Hogaboam
Antifungal and Airway Remodeling Roles for Murine Monocyte Chemoattractant Protein-1/CCL2 During Pulmonary Exposure to Asperigillus fumigatus Conidia
J. Immunol.,
February 1, 2001;
166(3):
1832 - 1842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. PASTEUR, S. M. HELLIWELL, S. J. HOUGHTON, S. C. WEBB, J. E. FOWERAKER, R. A. COULDEN, C. D. FLOWER, D. BILTON, and M. T. KEOGAN
An Investigation into Causative Factors in Patients with Bronchiectasis
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1277 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Blease, B. Mehrad, T. J. Standiford, N. W. Lukacs, J. Gosling, L. Boring, I. F. Charo, S. L. Kunkel, and C. M. Hogaboam
Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2-/- Mice
J. Immunol.,
September 1, 2000;
165(5):
2603 - 2611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Eaton, J. Garrett, D. Milne, A. Frankel, and A. U. Wells
Allergic Bronchopulmonary Aspergillosis in the Asthma Clinic : A Prospective Evaluation of CT in the Diagnostic Algorithm
Chest,
July 1, 2000;
118(1):
66 - 72.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Hogaboam, C. S. Gallinat, D. D. Taub, R. M. Strieter, S. L. Kunkel, and N. W. Lukacs
Immunomodulatory Role of C10 Chemokine in a Murine Model of Allergic Bronchopulmonary Aspergillosis
J. Immunol.,
May 15, 1999;
162(10):
6071 - 6079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Grunig, D. B. Corry, M. W. Leach, B. W.P. Seymour, V. P. Kurup, and D. M. Rennick
Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary Aspergillosis
J. Exp. Med.,
March 17, 1997;
185(6):
1089 - 1100.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|